- Company engages Launch Haus LLC, a digital agency, to grow its direct-to-consumer e-commerce business through a new marketing campaign
- Consilium Global Research (http://dtn.fm/P49cZ) projects a CAGR of nearly 100% for CIIX through FY2020, with revenues reaching $14.8 million
- CIIX has goal of becoming the largest Chinese publicly traded company in the legalized cannabidiol (CBD) market, with a target audience of the global Chinese-speaking community
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) goal of growing its global sales of hemp-based cannabidiol (CBD) products will be aided by its engagement of Launch Haus LLC, a Scottsdale, Arizona-based holding company specializing in digital direct-to-consumer marketing and product branding.
CIIX has a goal of becoming the primary Chinese medical cannabis publicly traded company. It is focused on the research and development and distribution of legalized CBD to the global Chinese-speaking community. It has an online store in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar store in its home market of San Gabriel, California. Sales of CBD are legal in China, while marijuana is not.
In a recent update, WallStreetResearch.org (http://dtn.fm/a4DV4) noted, “Launch Haus has been engaged to develop a customized cutting-edge direct response marketing campaign that will focus on personalized, customer-centric marketing and sales force automation; develop a compensation plan that incentivizes both rapid growth through recruitment of new, entry-level consumers and top-tier distributors; introduce CIIX to its stable of industry-leading suppliers for global payment systems and logistics and its network of distributor recruitment and legal governance and compliance professionals.”
The report added that the principals of Launch Haus have a proven track record of building sales organizations and developing go-to-market planning and customer experience consulting. CIIX, it notes, believes it is on track to announce an official launch date of its direct selling platform in the coming fiscal year.
Consilium Global Research projects that CIIX will achieve sales of $14.8 million by FY2020, outpacing the growth of the CBD market with a compound annual growth rate (CAGR) of nearly 100% in that time period.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment